FIELD: veterinary science.
SUBSTANCE: propose medication for cattle actinomycosis treatment contains an aqueous solution of the Aktinomyces bovis fungus cytoplasmic fraction containing albumens with a molecular weight from 20 kilodalton to 90 kilodalton, 1.1-1.3 mg/ml, cholesterol, 0.25-0.3.mM/l, triglicerides 0.9-1.0 mM/l, the water-active agent ratio being 1:1, and contains a 0.4% solution of formalin.
EFFECT: there is described medication for cattle actinomycosis treatment.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING A SPECIFIC IMMUNOMODULATOR | 2021 |
|
RU2764467C1 |
| COMPOSITION FOR MAINTAINING THE NORMAL STATE OF HOMEOSTASIS AND MEDICINAL PRODUCT BASED THEREON | 2021 |
|
RU2784067C1 |
| METHOD FOR PREPARING SPECIFIC IMMUNOMODULATOR | 2007 |
|
RU2366455C2 |
| AGENT OF ANTIMETASTATIC ACTION | 2007 |
|
RU2341271C1 |
| VACCINES OF RECOMBINANT INTRACELLULAR PATHOGENS AND USES THEREOF | 2001 |
|
RU2266132C2 |
| METHOD OF OBTAINING SPECIFIC IMMUNOMODULATOR | 2011 |
|
RU2478399C2 |
| HEPATOPROTECTIVE AGENT | 2017 |
|
RU2635762C1 |
| METHOD OF PROTECTION OF ANIMALS AT DIOXIN POISONING | 2014 |
|
RU2565406C1 |
| METHOD OF ESTIMATION OF TOLERANCE OF ORGANISM OF ANIMAL TO TUBERCULOSIS | 2007 |
|
RU2352938C1 |
| IMMUNOGENIC COMPOSITION (VERSIONS) BASED ON RECOMBINANT INTRACELLULAR PATHOGEN | 2003 |
|
RU2337707C2 |
